Trials / Completed
CompletedNCT02396680
Ragweed-SPIRE Follow-On Study
An Observational Follow-On Field Study to Evaluate the Continued Efficacy and Safety of Ragweed-SPIRE Treatment in Ragweed Allergic Subjects Approximately One Year After the Completion of Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 249 (actual)
- Sponsor
- Circassia Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy of Ragweed-SPIRE 12 months after the initial dose.
Conditions
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-02-01
- First posted
- 2015-03-24
- Last updated
- 2016-03-23
Locations
3 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02396680. Inclusion in this directory is not an endorsement.